Allogeneic Blood Transfusions

Introduction

August 2009

Welcome to Mayo Medical Laboratories' Hot Topics. These presentations provide short discussions of current topics and may be helpful to you in your practice.

Our speaker for this program is Dr. James Stubbs, Chair of the Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology at Mayo Clinic. Dr. Stubbs discusses the costs, risks, and benefits of allogenic blood transfusions. Dr. Stubbs reviews the Mayo Clinic experience and the development of evidence-based algorithms for determining when to transfuse.

Introduction

Next Slide >

 

Jump to section:

• Build A Case
• Well Established Risks
• Deaths
• Infectious Causes
• Leukocyte Alloimmunization and TRALI
• Leukocyte Alloimmunization and TRALI
• TRALI
• Allogeneic Blood Transfusion
• Transfusion Risks
• Adverse Outcomes Following ABT
• Adverse Outcomes Following ABT
• Adverse Outcomes Following ABT
• Transfusion Practice Variability: Do We Know What Were Doing?
• Transfusion Practice Variability
• Total Perioperative Transfusion Practice By Transfusion Product
• Transfusion Economics
• True Cost of Transfusion^3-5
• Blood Product Usage and Expense 2008 Mayo Clinic Rochester
• We Pay to Transfuse: Insured/Private Pay
• What Did We Get Paid?
• Blood Management
• Evidence-Based Red Cell Transfusion
• Evidence-Based Red Cell Transfusion
• Transfusion Expense Cardiac Surgery 2006-2008*
• Intraoperative Transfusions
• Intraoperative Transfusions
• Mayo-Implemented Operating Room Transfusion Algorithm
• Mayo-Implemented ICU Transfusion Algorithm
• Who Are We
• Conclusions
• Conclusions
• References
• Questions?